Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Marlon Brando was so enraged at the Italian premiere of his film On The Waterfront, he walked out of the cinema where he was ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Like Moses wandering the desert for 40 years, I had been roaming the aisles for the better part of 40 long minutes.

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Subscribers can play a remodeled version of the game that launched one of the most critically acclaimed gaming franchises.

TrampolineTales developer of the popular Luck be a Landlord slot machine deck-builder just announced Maze Mice and it really ...

Despite criticisms of his presidency, Jimmy Carter led major government reform efforts that had a lasting impact on agencies, ...

Enterprises succeed in their cloud journey by strategically choosing providers, building right the first time, monetizing ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

Maze Therapeutics (MAZE), which is developing treatments for chronic kidney disease, has filed to raise $100M through an ...